Vaccinations Related Content
Genomic characterisation for improved responses to dengue outbreaks in Tanzania
Gaspary Mwanyika from the SACIDS Foundation for One Health, Sokoine University of Agriculture, Tanzania details the importance of genomic characterisation in the control of dengue.
Lessons from the mouse model of cutaneous leishmaniasis
Peter Bretscher, from the University of Saskatchewan looks at whether mouse models of cutaneous leishmaniasis are pertinent for vaccination against and treatment of AIDS, infectious diseases, and cancer.
Should we be preparing for a widespread monkeypox outbreak?
This ‘unusual’ monkeypox outbreak has been found to be larger and more widespread than previous outbreaks outside of Africa, and health experts propose better preparation.
$70 billion in US healthcare costs saved by Pfizer vaccine rollout
The Pfizer vaccine saved up to $40 billion in healthcare costs and over 110,000 lives, in just one year of being rolled out to the US population.
Negative sentiments on social media influence vaccine hesitancy
Research examining Twitter opinion about vaccines shows that social media is a considerable factor influencing vaccine hesitancy.
WHO licensing agreement can improve access to COVID health technologies
The WHO licensing agreement with the Medicines Patent Pool (MPP) and US National Institutes of Health (NIH) should improve access to some COVID health technologies, like early-stage vaccines and diagnostic tools.
Understanding the immune system to create new malaria treatments
By analysing patient samples, researchers believe they now understand how the human immune system protects the body from malaria - opening the door to new malaria treatments.
How long does COVID pneumonia last?
Scientists describe COVID pneumonia as "multiple wildfires spreading across a forest" - but how different is the condition from regular pneumonia?
Could nanoparticle deception be a future COVID treatment?
Potential new COVID-19 treatment may see decoy nanoparticles trick the life-threatening virus and render them inactive
Scientists say low risk of myopericarditis after COVID vaccination
A study finds that the risk of myopericarditis after COVID vaccination is low, or equivalent to the risks posed by vaccines against other diseases.
Powerful new COVID treatment cuts hospital deaths by 55%
So far, there is no treatment for severe cases - but now, clinical trials for a new COVID treatment show immense promise in preventing death.
XE COVID variant 10% more transmissible than Omicron
The World Health Organisation (WHO) say that the XE COVID variant (a mixture of two strains of Omicron) could be 10% more transmissible than Omicron itself.
Inflammation from COVID-19 can cause multi-organ damage
Severe cases of inflammation from COVID-19 can occur in some people – leading to cases of acute respiratory distress and multi-organ damage.
Understanding Flaviviruses: Deciphering insect-borne virus strategies
Understanding the infection strategy of mosquito-borne viruses known as flaviviruses is key in the future development of treatments and possible vaccines
Non-English speaking patients have 35% higher chance of COVID death
Non-English speaking patients with COVID have a higher likelihood of needing ICU care and dying from the virus, say US scientists.
Scientists develop Omicron variant vaccine against COVID
MedUni Vienna delivers promising data to the Omicron variant vaccine which could protect people against all known variants of the SARS-CoV-2 virus.
Which is the better protection against COVID-19? Immunity or vaccination?
Researchers find the best protection against COVID-19 is vaccinations rather than natural immunity, when analysing how infection with SARS-CoV-2 affects the immune system.
Survivors with COVID-19 pneumonia take one year to heal
People who survive COVID-19 pneumonia, take at least one year to heal their lungs, according to a study published in Radiology.
Pregnancy and COVID vaccine: Mothers can protect unborn baby from virus
In the context of pregnancy and COVID vaccines, a study finds that vaccination does not create complicated birth outcomes.
Global COVID-19 responses could help to end HIV
Global COVID-19 responses could serve as a coordinated approach to end the HIV pandemic - bettering global immunisation to both viruses.